ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...
Companies spend billions on programs that don’t pay off. Here’s how to fix that. by Michael Beer, Magnus Finnström and Derek Schrader Corporations are victims of the great training robbery. American ...
Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...